Elevated phosphorylated MEK and ERK concentration was revealed for BRAF L597Q/R/S expression, and in vitro and in vivo tumor regression was shown for L597S- and L597Q-mutated melanoma when treated with a MEKi [24, 27]. Here, BRAF is linked to neoplasm.